natgillin/translations-raw huggingface dataset:
In addition, signs and symptoms of beta-blockade (e.g. bradycardia, hypotension, respiratory distress and hypoglycaemia) have been observed in the neonate when beta-blockers have been administered until delivery. 
Osim toga, kada su beta-blokatori davani do poroda, kod novorođenčadi su zabilježeni znakovi i simptomi beta-blokade (npr.
GANFORT single-dose can affect or be affected by other medicines you are using, including other eye drops for the treatment of glaucoma. 
Na jednodozni GANFORT mogu utjecati drugi primijenjeni lijekovi, ili on može utjecati na njih,
Hepatic 
adrenalina.
PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON CONTAINING 30 SINGLE-DOSE CONTAINERS (PROVIDED IN 3 POUCHES, EACH CONTAINING 10 SINGLE-DOSE CONTAINERS) 
KUTIJA KOJA SADRŽI 30 JEDNODOZNIH SPREMNIKA (ISPORUČENIH
MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS POUCH CONTAINING STRIP OF 10 SINGLE-DOSE CONTAINERS 
VREĆICA KOJA SADRŽI STRIP S 10 JEDNODOZNIH SPREMNIKA
Use any eye ointment or eye gel last. 
Ako trebate primijeniti mast za oko ili gel za oko, učinite to na kraju.
- disturbances of heart rate such as slow heart beat - breathing problems, asthma or chronic obstructive pulmonary disease - poor blood circulation disease (such as Raynaud's disease or Raynaud's syndrome) - overactivity of the thyroid gland as timolol may mask signs and symptoms of thyroid disease - diabetes as timolol may mask signs and symptoms of low blood sugar - severe allergic reactions - liver or kidney problems - eye surface problems - separation of one of the layers within the eyeball after surgery to reduce the pressure in the eye - known risk factors for macular oedema (swelling of the retina within the eye leading to worsening vision), for example, cataract surgery 
- slabe cirkulacije (bolesti perifernih krvnih žila kao što je Raynaudova bolest ili Raynaudov sindrom), - pojačane aktivnosti štitne žlijezde, jer timolol može zamaskirati znakove i simptome bolesti štitne žlijezde,
- if you are allergic to bimatoprost, timolol, beta-blockers or any of the other ingredients of GANFORT single-dose (listed in section 6) - if you have now or have had in past respiratory problems such as asthma, severe chronic obstructive bronchitis (severe lung disease which may cause wheeziness, difficulty in breathing and/ or long-standing cough) - if you have heart problems such as low heart rate, heart block, or heart failure 
- koronarne bolesti srca (simptomi mogu uključivati bol ili stezanje u prsnom košu, nedostatak zraka ili gušenje), srčanog zatajenja, niskog krvnog tlaka, - poremećaja otkucaja srca kao što su spori otkucaji srca, - dišnih problema, astme ili kronične opstruktivne bolesti pluća
However, consideration should be given to the likelihood of compliance when considering either morning or evening dosing. 
Ipak prilikom propisivanja treba uzeti u obzir odgovara li bolesniku vrijeme primjene, odnosno kada je vjerojatnije da će bolesnik propisani lijek primijeniti.
• go to the hospital straight away 
• odmah otiđite u bolnicu
June 2023 
Lipanj 2023
• Take this medicine by mouth. 
• Uzmite ovaj lijek kroz usta.
There were no grade 3 or 4 adverse events. 
Nije bilo događaja 3. ni 4. stupnja.
While the overall number of events was small, the difference between the two arms was sufficiently large to reach statistical significance. 
Dok je ukupni broj događaja bio mali, razlika između dvije skupine je bila dovoljno velika za dostizanje statističkog značaja.
• has not metastasised to other parts of the body and 
• koji se nije proširio (metastazirao) u druge dijelove tijela i
Children and adolescents This medicine is not for use in children and adolescents under 18 years of age. 
Ovaj se lijek ne smije primjenjivati u djece i adolescenata mlađih od 18 godina.
Talk to your doctor if you have any questions about contraception. 
Obratite se svom liječniku ako imate bilo kakvih pitanja o kontracepciji.
What Erleada is and what it is used for 
Što je Erleada i za što se koristi
Each carton contains one bottle. 
Jedno pakiranje sadrži jednu bocu.
Androgens can cause the cancer to grow. 
Androgeni mogu uzrokovati rast raka.
• You can take Erleada with food or between meals. 
• Lijek Erleada možete uzeti s hranom ili između obroka.
Do not take this medicine if any of the above apply to you. 
Nemojte uzimati ovaj lijek ako se bilo što od gore navedenoga odnosi na Vas.
If a child or young person accidentally takes Erleada: 
Ako dijete ili mlada osoba slučajno uzmu lijek Erleada:
The median time to symptomatic progression was not reached in either treatment group. 
Medijan vremena do simptomatske progresije nije dostignut ni u jednoj liječenoj skupini.
The tablets should be swallowed whole and can be taken with or without food. 
Tablete treba progutati cijele, a mogu se uzimati s hranom ili bez nje.
Pregnancy and contraception information for men and women 
Informacije o trudnoći i kontracepciji za muškarce i žene
Ethnicity and race 
Etnička pripadnost i rasa
Therefore, the safety of apalutamide in these patients has not been established. 
Stoga nije utvrđena sigurnost apalutamida u tih bolesnika.
(2) Pull out 
(2) Izvucite
If you are at higher risk of seizures (see Section 2), talk to your doctor. 
Ako kod Vas postoji povećan rizik od napadaja (pogledajte dio 2.), razgovarajte sa svojim liječnikom.
OTHER Fold over to close 
Preklopite da biste zatvorili
Tell your doctor straight away if you notice any of the following serious side effects - your doctor may stop treatment: 
Odmah se obratite svom liječniku ako se pojavi bilo koja od sljedećih ozbiljnih nuspojava - liječnik će možda prekinuti liječenje:
If you are taking any medicines, talk to your doctor or pharmacist to see if they are associated with an increased risk of seizure, bleeding, or heart condition. 
Ako uzimate bilo koji lijek, razgovarajte sa svojim liječnikom ili ljekarnikom kako biste vidjeli jesu li ti lijekovi povezani s povećanim rizikom od napadaja, krvarenja ili srčane bolesti.
Information for men - follow this advice during treatment and for 3 months after stopping 
Informacije za muškarce - pridržavajte se ovih savjeta tijekom liječenja i još 3 mjeseca nakon što liječenje završi
• you are allergic to apalutamide or any of the other ingredients of this medicine (listed in section 6). 
• ako ste alergični na apalutamid ili neki drugi sastojak ovog lijeka (naveden u dijelu 6.)
The reduction in plasma concentrations can be substantial, and lead to lost or reduced clinical effect. 
Sniženje plazmatskih koncentracija može biti znatno i dovesti do gubitka ili smanjenja kliničkog učinka.
There is also a risk of increased formation of active metabolites. 
Postoji i rizik od pojačanog stvaranja aktivnih metabolita.
The median days to onset of skin rash was 82 days with a range of 1 to 994 days. 
Medijan vremena do nastupa kožnog osipa iznosio je 82 dana, uz raspon od 1 do 994 dana.
Frequency categories are defined as follows: very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); rare (≥ 1/10,000 to < 1/1,000); very rare (< 1/10,000) and not known (frequency cannot be estimated from the available data). 
Učestalost pojavljivanja definirana je kao: vrlo često (≥ 1/10); često (≥ 1/100 i < 1/10); manje često (≥ 1/1000 i < 1/100); rijetko (≥ 1/10 000 i < 1/1000); vrlo rijetko (< 1/10 000) i nepoznato (učestalost se ne može procijeniti iz dostupnih podataka).
You need to list the names of the medicines you take and show the list to your doctor or pharmacist when you start a new medicine. 
Trebali biste sastaviti popis s nazivima lijekova koje uzimate i pokazati taj popis svom liječniku ili ljekarniku kad započinjete liječenje nekim novim lijekom.
PSA results were blinded and were not used for treatment discontinuation. 
Rezultati za PSA bili su zaslijepljeni i nisu se koristili za obustavu liječenja.
Elderly No dose adjustment is necessary for elderly patients (see sections 5.1 and 5.2). 
Nije potrebno prilagođavati dozu u starijih bolesnika (vidjeti dijelove 5.1 i 5.2).
All subjects who were not surgically castrated received ADT continuously throughout the study. 
Svi ispitanici koji nisu bili podvrgnuti kirurškoj kastraciji kontinuirano su primali ADT tijekom cijelog ispitivanja.
It is used to treat adult men with prostate cancer that: 
Koristi se za liječenje odraslih muškaraca s rakom prostate:
If you forget to take Erleada, take your usual dose as soon as you remember. 
Ako ste zaboravili uzeti lijek Erleada, uzmite uobičajenu dozu čim se sjetite.
Erleada works by blocking the activity of hormones called androgens (such as testosterone). 
Erleada djeluje tako da blokira aktivnost hormona koji se zovu androgeni (kao što je testosteron).
Medicinal products utilised included topical corticosteroids, systemic corticosteroids and oral anti-histamines. 
Lijekovi koji su se koristili uključivali su topikalne kortikosteroide, sistemske kortikosteroide i oralne antihistaminike.
Other important adverse reactions include fractures (12%) and hypothyroidism (8%). 
Druge važne nuspojave uključuju prijelome (12%) i hipotireozu (8%).
Pharmacotherapeutic group: Endocrine therapy, anti-androgens, ATC code: L02BB05 
Farmakoterapijska skupina: Endokrina terapija, anti-androgeni; ATK oznaka: L02BB05
Effects on male rats were reversible after 8 weeks from the last apalutamide administration. 
Učinci na mužjake štakora povukli su se 8 tjedana nakon posljednje doze apalutamida.
Table 1: Adverse reactions identified in clinical studies 
Tablica 1: Nuspojave utvrđene u kliničkim ispitivanjima
Patients should be advised of this risk in regards to driving or operating machines. 
Bolesnike treba upozoriti na taj rizik kod upravljanja vozilima ili rada sa strojevima.
Population pharmacokinetic analyses showed that age (range: 18 to 94 years) does not have a clinically meaningful influence on the pharmacokinetics of apalutamide. 
Populacijske farmakokinetičke analize pokazale su da dob (raspon: 18 - 94 godine) nema klinički značajnog utjecaja na farmakokinetiku apalutamida.
• treat gastroesophageal reflux disease (conditions where there is too much acid in the stomach) 
• liječenje gastroezofagusne refluksne bolesti (stanja kod kojega ima previše kiseline u želucu)
The racial distribution was 66% Caucasian, 5.6% Black, 12% Asian, and 0.2% Other. 
Rasna raspodjela bila je sljedeća: 66% bijelaca, 5,6% crnaca, 12% Azijaca i 0,2% ostalih.
Take extra care to reduce your risk of a fall. 
Budite posebno oprezni kako biste smanjili rizik od padova.
Seventy-seven percent (77%) of subjects in both treatment arms had prior surgery or radiotherapy of the prostate. 
Sedamdeset i sedam posto (77%) ispitanika u obje liječene skupine prethodno je bilo podvrgnuto kirurškom zahvatu ili radioterapiji prostate.
(1) Press and hold 
(1) Pritisnite i držite
Substitution for these medicinal products is recommended when possible or evaluation for loss of efficacy should be performed if the medicinal product is continued. 
Preporučuje se zamijeniti te lijekove drugima kad je to moguće ili je potrebna procjena mogućeg gubitka djelotvornosti ako se njihova primjena nastavi.
Other medicines and Erleada 
Drugi lijekovi i Erleada
A majority of subjects had a Gleason score of 7 or higher (81%). 
Većina ispitanika imala je Gleasonov zbroj 7 ili više (81%).
If a dose is missed, it should be taken as soon as possible on the same day with a return to the normal schedule the following day. 
Ako bolesnik propusti uzeti dozu lijeka, treba je uzeti što je prije moguće istoga dana, a zatim sljedeći dan nastaviti liječenje prema uobičajenom rasporedu.
Use contraception during treatment and for 3 months after stopping. 
Koristite kontracepciju tijekom liječenja i još 3 mjeseca po njegovu završetku.
The following patient demographics and baseline disease characteristics were balanced between the treatment arms. 
Sljedeće demografske značajke bolesnika i početne značajke bolesti bile su uravnotežene između liječenih skupina.
Not known (frequency cannot be estimated from the available data): • abnormal heart tracing on an ECG (electrocardiogram) 
Nepoznato (učestalost se ne može procijeniti iz dostupnih podataka): • poremećaj srčane aktivnosti vidljiv na elektrokardiogramu (EKG)
• take this package leaflet with you to show to the emergency doctor. 
• ponesite ovu uputu o lijeku sa sobom i pokažite je liječniku u hitnoj službi
The median age was 74 years (range 48-97) and 26% of subjects were 80 years of age or older. 
Medijan dobi iznosio je 74 godine (raspon: 48 - 97), a 26% ispitanika imalo je 80 ili više godina.
It is not known whether apalutamide or its metabolites are present in semen. 
Nije poznato jesu li apalutamid ili njegovi metaboliti prisutni u spermi.
• you have ever had fits or seizures 
• ako ste ikada imali napadaje
Erleada may harm your unborn baby. 
Erleada može naškoditi nerođenom djetetu.
• you are a woman who is pregnant or may become pregnant (see the Pregnancy and contraception section below for more information). 
• ako ste trudnica ili žena koja bi mogla zatrudnjeti (pogledajte dio „Trudnoća i kontracepcija” u nastavku za više informacija)
Figure 1: Kaplan-Meier metastasis-free survival (MFS) curve in Study ARN-509-003 
Slika 1: Kaplan-Meierova krivulja preživljenja bez metastaza (MFS) u ispitivanju ARN-509-003
The risk of seizure may be increased in patients receiving concomitant medicinal products that lower the seizure threshold. 
Rizik od napadaja može biti povećan u bolesnika koji istodobno primaju lijekove koji snižavaju prag za napadaje.
• lower cholesterol levels (e.g. ‘statins' such as rosuvastatin, simvastatin) 
• snižavanje razina kolesterola (npr. ‘statine', kao što su rosuvastatin, simvastatin)
Tell your healthcare provider right away if you notice any of the serious side effects above. 
Odmah obavijestite svog liječnika ako primijetite bilo koju od gore navedenih ozbiljnih nuspojava.
If you are not sure, talk to your doctor or pharmacist before taking this medicine. 
Ako niste sigurni, razgovarajte sa svojim liječnikom ili ljekarnikom prije nego uzmete ovaj lijek.
• If you forget to take Erleada for more than one day - talk to your doctor straight away. 
• Ako ste zaboravili uzeti lijek Erleada više od jednog dana - odmah se obratite svom liječniku.
Do not take Erleada if: 
Nemojte uzimati lijek Erleada:
Median time to reach tmax was delayed about 2 hours with food (see section 4.2). 
Medijan vremena do postizanja tmax produljio se za približno 2 sata kod primjene s hranom (vidjeti dio 4.2).
The dose of Erleada or any other medicines that you are taking may need to be changed. 
Možda će trebati promijeniti dozu lijeka Erleada ili nekog drugog lijeka koji uzimate.
If you take more Erleada than you should 
Ako uzmete više lijeka Erleada nego što ste trebali
Seventy-three percent (73%) of subjects received prior treatment with a first generation anti-androgen; 69% of subjects received bicalutamide and 10% of subjects received flutamide. 
Sedamdeset i tri posto (73%) ispitanika prethodno se liječilo antiandrogenom prve generacije; 69% ispitanika primalo je bikalutamid, a 10% njih flutamid.
Among patients with skin rash, dose interruption occurred in 28% and dose reduction occurred in 12% (see section 4.2). 
Među bolesnicima s kožnim osipom, primjena lijeka privremeno je prekinuta u 28% bolesnika, a doza je smanjena u 12% bolesnika (vidjeti dio 4.2).
• If you are having sex with a pregnant woman - use a condom to protect the unborn baby. 
• Ako imate spolni odnos s trudnicom - Vi i vaša partnerica trebate koristiti prezervativ kako biste zaštitili nerođeno dijete.
Co-administration with warfarin and coumarin-like anticoagulants should be avoided. 
Treba izbjegavati istodobnu primjenu s varfarinom i antikoagulansima kumarinskog tipa.
Long-term animal studies have not been conducted to evaluate the carcinogenic potential of apalutamide. 
Nisu provedena dugotrajna ispitivanja na životinjama kojima bi se ocijenio kancerogeni potencijal apalutamida.
The effect of apalutamide on CYP2B6 substrates has not been evaluated in vivo and the net effect is presently unknown. 
Učinak apalutamida na supstrate CYP2B6 nije se procjenjivao in vivo pa neto učinak trenutno nije poznat.
• under-active thyroid which can make you feel more tired and have difficulty getting started in the morning, and blood tests may also show an under-active thyroid 
• smanjena aktivnost štitnjače, zbog čega se možete osjećati umornije i imati poteškoća s razbuđivanjem ujutro, a koja također može biti vidljiva u nalazima krvnih pretraga
For patients having sex with female partners of reproductive potential, a condom should be used along with another highly effective contraceptive method during treatment and for 3 months after the last dose of Erleada. 
Ako bolesnici i njihove partnerice reproduktivne dobi imaju spolne odnose trebaju koristiti prezervativ u kombinaciji s još jednom visoko učinkovitom metodom kontracepcije tijekom liječenja i još 3 mjeseca nakon posljednje doze lijeka Erleada.
Metabolism is the main route of elimination of apalutamide. 
Metabolizam je glavni put eliminacije apalutamida.
Administration of apalutamide to healthy subjects under fasting conditions and with a high-fat meal resulted in no clinically relevant changes in Cmax and AUC. 
Primjena apalutamida zdravim ispitanicima natašte i uz obrok s visokim udjelom masti nije dovela do klinički značajnih promjena vrijednosti Cmax i AUC-a.
Skin rash associated with Erleada was most commonly described as macular or maculo-papular. 
Kožni osip povezan s primjenom lijeka Erleada najčešće se opisivao kao makularni ili makulo-papularni.
Adverse reactions in the event of an overdose has not yet been observed, it is expected that such reactions would resemble the adverse reactions listed in section 4.8. 
Još nisu opažene nuspojave u slučaju predoziranja, ali očekuje se da bi bile slične nuspojavama navedenima u dijelu 4.8.
The tablets are supplied in a plastic bottle with a child-resistant closure. 
Tablete dolaze u plastičnoj boci sa zatvaračem sigurnim za djecu.
Based on population pharmacokinetic analysis, there were no clinically relevant differences in apalutamide pharmacokinetics between White (Caucasian or Hispanic or Latino; N=761), Black (of African heritage or African American; N=71), Asian (non-Japanese; N=58) and Japanese (N=58). 
Prema populacijskoj farmakokinetičkoj analizi, nije bilo klinički značajnih razlika u farmakokinetici apalutamida između bijelaca (europeidi, Hispanoamerikanci ili Latinoamerikanci; N=761), crnaca (crnci afričkog porijekla ili Afroamerikanci; N=71), Azijaca (izuzevši Japanace; N=58) i Japanaca (N=58).
Tell your doctor if you are taking medicines that: 
Obavijestite svog liječnika ako uzimate lijekove za:
Women who are or may become pregnant (see section 4.6). 
Trudnice ili žene koje bi mogle zatrudnjeti (vidjeti dio 4.6).
Clinical and pharmacokinetic data are not available for patients with severe hepatic impairment (Child-Pugh Class C). 
Nisu dostupni klinički ni farmakokinetički podaci za bolesnike s teškim oštećenjem jetrene funkcije (Child-Pugh stadij C).
Based on animal studies, Erleada may decrease fertility in males of reproductive potential (see section 5.3). 
S obzirom na ispitivanja na životinjama, Erleada može smanjiti plodnost u muškaraca reproduktivne dobi (vidjeti dio 5.3).
• no longer responds to medical or surgical treatment that lowers testosterone (also called castration-resistant prostate cancer). 
• koji više ne odgovara na farmakološko (primjenom lijekova) ili kirurško liječenje koje snizuje razine testosterona (naziva se još i rakom prostate rezistentnim na kastraciju)
If a ≥ Grade 3 toxicity or an intolerable adverse reaction is experienced by the patient, dosing should be held rather than permanently discontinuing treatment until symptoms improve to ≤ Grade 1 or original grade, then should be resumed at the same dose or a reduced dose (180 mg or 120 mg), if warranted. 
Ako se u bolesnika pojavi toksičnost ≥ 3. stupnja ili nepodnošljiva nuspojava, umjesto trajne obustave liječenja potrebno je odgoditi doziranje lijeka dok se simptomi ne poboljšaju do ≤ 1. stupnja ili početne težine, a zatim je potrebno nastaviti liječenje istom ili smanjenom dozom (180 mg ili 120 mg), ako je to opravdano.
Time to symptomatic progression was defined as time from randomization to development of a skeletal related event, pain/symptoms requiring initiation of a new systemic anti-cancer therapy, or loco-regional tumor progression requiring radiation/surgery. 
Vrijeme do simptomatske progresije definiralo se kao vrijeme od randomizacije do razvoja koštanog događaja, pojave boli/simptoma koji zahtijevaju uvođenje nove sistemske protutumorske terapije ili lokoregionalne progresije tumora koja iziskuje zračenje/kirurški zahvat.
Cardiac disorders not known: QT prolongation (see sections 4.4 and 4.5) 
Srčani poremećaji nepoznato: produljenje QT intervala (vidjeti dijelove 4.4 i 4.5.)
The median MFS for Erleada was 41 months and was 16 months for placebo (see Figure 1. 
Medijan MFS-a uz lijek Erleada iznosio je 41 mjesec, a uz placebo 16 mjeseci (vidjeti Sliku 1.
Erleada may reduce male fertility. 
Erleada može smanjiti plodnost muškaraca.
Your healthcare provider may monitor you more closely if you are at risk for fractures. 
Liječnik će Vas možda pažljivije nadzirati ako kod Vas postoji rizik od prijeloma.
The most common adverse reactions are fatigue (30%), skin rash (24% of any grade and 5% Grade 3 or 4), weight decreased (16%), arthralgia (16%), and fall (16%). 
Najčešće su nuspojave umor (30%), kožni osip (24% za osip bilo kojeg stupnja i 5% za osip 3. ili 4. stupnja), smanjenje tjelesne težine (16%), artralgija (16%) i pad (16%).
Extra tablets should not be taken to make up the missed dose. 
Bolesnik ne smije uzeti dodatne tablete da bi nadoknadio propuštenu dozu.
Fifteen percent (15%) of subjects had < 2 cm pelvic lymph nodes at study entry. 
Petnaest posto (15%) ispitanika imalo je zdjelične limfne čvorove veličine < 2 cm pri uključivanju u ispitivanje.
Endocrine disorders common: hypothyroidism* 
Endokrini poremećaji često: hipotireoza*
There is no relevant use of apalutamide in the paediatric population in the treatment of non-metastatic castration-resistant prostate cancer. 
Nema relevantne primjene apalutamida u pedijatrijskoj populaciji za liječenje nemetastatskog raka prostate rezistentnog na kastraciju.
The mean effective half-life for apalutamide in patients is about 3 days at steady-state. 
Srednja vrijednost efektivnog poluvijeka apalutamida u bolesnika iznosi približno 3 dana u stanju dinamičke ravnoteže.
In the event of an overdose, Erleada should be stopped and general supportive measures should be undertaken until clinical toxicity has been diminished or resolved. 
U slučaju predoziranja potrebno je prekinuti primjenu lijeka Erleada te uvesti opće potporne mjere dok se klinička toksičnost ne smanji ili povuče.
Erleada is indicated in adult men for the treatment of non-metastatic castration-resistant prostate cancer (NM-CRPC) who are at high risk of developing metastatic disease (see section 5.1). 
Erleada je indicirana za liječenje nemetastatskog raka prostate rezistentnog na kastraciju (engl. non-metastatic castration-resistant prostate cancer, NM-CRPC) u odraslih muškaraca u kojih postoji visok rizik od razvoja metastatske bolesti (vidjeti dio 5.1).
Half of the patients experienced a fall within 7 days before the fracture event in both treatment groups. 
U obje je liječene skupine polovica bolesnika doživjela pad unutar 7 dana prije događaja prijeloma.
Treatment with apalutamide should be initiated and supervised by specialist physicians experienced in the medical treatment of prostate cancer. 
Liječenje apalutamidom treba započeti i nadzirati liječnik spacijalist s iskustvom u liječenju raka prostate.
28-day carton 
28-dnevno pakiranje
If you take more than you should, stop taking Erleada and contact your doctor. 
Ako uzmete više tableta nego što ste trebali, prestanite uzimati lijek Erleada i obratite se svom liječniku.
For the most common adverse reactions, see section 4.8. 
Za najčešće nuspojave vidjeti dio 4.8.
Talk to your doctor or pharmacist before taking this medicine if: 
Obratite se svom liječniku ili ljekarniku prije nego uzmete ovaj lijek: